HeartSciences (HSCS) Competitors $3.05 -0.07 (-2.24%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.21 +0.16 (+5.21%) As of 08/1/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSCS vs. INBS, XAIR, BDMD, MHUA, BTCY, DHAI, WOK, LYRA, PAVM, and CODXShould you be buying HeartSciences stock or one of its competitors? The main competitors of HeartSciences include Intelligent Bio Solutions (INBS), Beyond Air (XAIR), Baird Medical Investment (BDMD), Meihua International Medical Technologies (MHUA), Biotricity (BTCY), DIH Holding US (DHAI), WORK Medical Technology Group (WOK), Lyra Therapeutics (LYRA), PAVmed (PAVM), and Co-Diagnostics (CODX). These companies are all part of the "medical equipment" industry. HeartSciences vs. Its Competitors Intelligent Bio Solutions Beyond Air Baird Medical Investment Meihua International Medical Technologies Biotricity DIH Holding US WORK Medical Technology Group Lyra Therapeutics PAVmed Co-Diagnostics HeartSciences (NASDAQ:HSCS) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Is HSCS or INBS more profitable? HeartSciences has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -319.85%. Intelligent Bio Solutions' return on equity of -176.55% beat HeartSciences' return on equity.Company Net Margins Return on Equity Return on Assets HeartSciencesN/A -293.60% -135.39% Intelligent Bio Solutions -319.85%-176.55%-93.89% Which has more volatility and risk, HSCS or INBS? HeartSciences has a beta of 2.57, suggesting that its share price is 157% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.6, suggesting that its share price is 360% more volatile than the S&P 500. Do insiders & institutionals hold more shares of HSCS or INBS? 17.2% of HeartSciences shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 1.8% of HeartSciences shares are held by company insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Do analysts rate HSCS or INBS? HeartSciences currently has a consensus target price of $13.00, suggesting a potential upside of 326.23%. Given HeartSciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe HeartSciences is more favorable than Intelligent Bio Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Intelligent Bio Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has stronger earnings & valuation, HSCS or INBS? HeartSciences has higher earnings, but lower revenue than Intelligent Bio Solutions. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeartSciences$4.35K757.94-$8.77M-$9.36-0.33Intelligent Bio Solutions$2.94M3.46-$10.16MN/AN/A Does the media prefer HSCS or INBS? In the previous week, HeartSciences had 4 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 5 mentions for HeartSciences and 1 mentions for Intelligent Bio Solutions. HeartSciences' average media sentiment score of 0.13 beat Intelligent Bio Solutions' score of 0.00 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intelligent Bio Solutions 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryHeartSciences beats Intelligent Bio Solutions on 9 of the 14 factors compared between the two stocks. Get HeartSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HSCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeartSciencesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.37M$2.04B$5.48B$9.51BDividend YieldN/AN/A4.73%4.08%P/E Ratio-0.3333.7928.6723.80Price / Sales757.9428.84373.9066.65Price / CashN/A56.2135.4557.96Price / Book16.058.978.275.55Net Income-$8.77M-$62.31M$3.24B$259.03M7 Day Performance-22.59%-8.15%-3.69%-4.59%1 Month Performance-19.31%1.83%4.33%4.46%1 Year Performance-15.28%21.01%25.95%18.03% HeartSciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeartSciences2.287 of 5 stars$3.05-2.2%$13.00+326.2%-21.6%$3.37M$4.35K-0.3310News CoverageUpcoming EarningsGap UpINBSIntelligent Bio Solutions0.5811 of 5 stars$2.25+10.8%N/A+9.7%$15.55M$3.11M0.0010XAIRBeyond Air3.6968 of 5 stars$3.40+2.4%$23.67+596.1%-74.0%$14.69M$3.71M-0.2270Short Interest ↑High Trading VolumeBDMDBaird Medical InvestmentN/A$2.17-29.1%N/AN/A$14.28MN/A0.00N/AGap DownHigh Trading VolumeMHUAMeihua International Medical Technologies1.6085 of 5 stars$0.41-5.4%N/A-59.9%$13.03M$96.90M0.00620Positive NewsBTCYBiotricityN/A$0.51+6.3%N/A-40.4%$12.71M$12.06M-0.4740Gap DownDHAIDIH Holding US0.5974 of 5 stars$0.26-11.0%N/A-91.5%$12.42M$64.47M-0.87N/ANews CoverageHigh Trading VolumeWOKWORK Medical Technology GroupN/A$0.78-4.8%N/AN/A$11.38M$11.51M0.00226LYRALyra Therapeutics2.9764 of 5 stars$8.20+0.6%$100.00+1,119.5%-57.0%$10.91M$1.53M-0.1450Positive NewsPAVMPAVmed4.4348 of 5 stars$0.59-1.5%$19.00+3,131.3%-34.5%$10.05M$1.99M0.8390News CoveragePositive NewsCODXCo-Diagnostics3.7961 of 5 stars$0.29+3.9%$5.50+1,768.2%-77.6%$9.88M$3.71M-0.25100News CoveragePositive NewsUpcoming EarningsShort Interest ↑High Trading Volume Related Companies and Tools Related Companies Intelligent Bio Solutions Competitors Beyond Air Competitors Baird Medical Investment Competitors Meihua International Medical Technologies Competitors Biotricity Competitors DIH Holding US Competitors WORK Medical Technology Group Competitors Lyra Therapeutics Competitors PAVmed Competitors Co-Diagnostics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSCS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
